Genotype- and Phenotype-Directed Personalization of Antiplatelet Treatment in Patients with Non-ST Elevation Acute Coronary Syndromes Undergoing Coronary Stenting

BACKGROUND AND OBJECTIVES: We evaluated the effectiveness of genotype- and phenotype-directed individualization of P2Y(12) inhibitors to decrease high on-treatment platelet reactivity (HOPR). SUBJECTS AND METHODS: Sixty-five patients undergoing percutaneous coronary intervention for non-ST elevation...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Sung Gyun, Yoon, Junghan, Kim, Juwon, Uh, Young, Kim, Kyung Min, Lee, Ji Hyun, Lee, Jun-Won, Youn, Young Jin, Ahn, Min-Soo, Kim, Jang-Young, Yoo, Byung-Su, Lee, Seung-Hwan, Tahk, Seung-Jea, Choe, Kyung-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772299/
https://www.ncbi.nlm.nih.gov/pubmed/24044013
http://dx.doi.org/10.4070/kcj.2013.43.8.541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772299/
https://www.ncbi.nlm.nih.gov/pubmed/24044013
http://dx.doi.org/10.4070/kcj.2013.43.8.541

Ejemplares similares